Quick Answer
Akso Health Group reported Cash and Equivalents of $176.23 million for fiscal year 2025.
Akso Health Group Cash and Equivalents — Annual History
| Fiscal Year | Cash and Equivalents | YoY Change |
|---|---|---|
| 2025 | $176.23M | +106.9% |
| 2024 | $85.17M | +974.8% |
| 2023 | $7.92M | -57.0% |
| 2022 | $18.43M | +21.8% |
| 2021 | $15.13M | +126.9% |
| 2020 | $6.67M | -88.4% |
| 2019 | $57.37M | -56.7% |
| 2018 | $132.62M | +589.6% |
| 2017 | $19.23M | +146.0% |
| 2016 | $7.82M | +719.0% |
| 2015 | $954.7K | — |
- Akso Health Group showed an increase of +106.9% in Cash and Equivalents compared to the prior fiscal year.
- Over the 2015–2025 period, Akso Health Group’s cash and equivalents has grown by 18359.6% (from $954.7 thousand to $176.23 million).
- The most recent figure is from Akso Health Group’s fiscal year 2025 report (Form 20-F), filed with the SEC on August 14, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: